JAGX (Jaguar Health, Inc.) Earnings growth forecast for next year

JAGX (Jaguar Health, Inc.) - company brandmark

Critical resource shortages and losses have triggered volatility, as reflected in the historical next-year EPS forecast trend on the GURU.Markets service chart, where the indicator stands at 0.00. The stability of Jaguar Health, Inc. (JAGX) relies on sales of its botanical remedy for HIV-associated diarrhea, while business development is driven by ESG-oriented pharmacological scientists incentivized by RSU options.

JAGX: Jaguar Health Corp Net earnings per one share growth forecast for next year 07/04/2022 - 11/18/2026

Analytical breakdowns and data insights for company Jaguar Health Inc (JAGX)

Fundamental company valuation:Jaguar Health, Inc.
Finished products of Jaguar Health

A stable roster of researchers and targeted reinforcement of the commercial division at Jaguar Health, Inc. (JAGX) lay the foundation for revenue scaling. This indicator measures the gap between current yield and the consensus EPS forecast, reflecting market confidence in the monetization of scientific developments, which allows the trend of consensus earnings per share estimates to determine the risk of capital stagnation during a market cycle shift.